I. Leimer

发表

Patients With COPD Cardiovascular Safety of Tiotropium in

M. Decramer, B. Celli, D. Tashkin, 2010 .

Cardiac safety of tiotropium in patients with cardiac events: a retrospective analysis of the UPLIFT® trial

M. Decramer, D. Tashkin, N. Metzdorf, 2015, Respiratory Research.

Effect of Tiotropium on Outcomes in Patients With COPD, Categorized Using the New GOLD Grading System: Results of the UPLIFT® Randomized Controlled Trial.

M. Decramer, B. Celli, D. Halpin, 2015, Chronic obstructive pulmonary diseases.

Risk of major adverse cardiovascular events with inhaled anticholinergics in patients with chronic obstructive pulmonary disease.

S. Kesten, I. Leimer, Michele Jara, 2009, JAMA.

Cardiovascular safety of tiotropium in patients with COPD.

M. Decramer, B. Celli, D. Tashkin, 2010, Chest.

Responses to tiotropium in African-American and Caucasian patients with chronic obstructive pulmonary disease.

D. Niewoehner, K. Rice, S. Kesten, 2008, Translational research : the journal of laboratory and clinical medicine.

Tiotropium reduces risk of exacerbations irrespective of previous use of inhaled anticholinergics in placebo-controlled clinical trials

M. Decramer, A. Anzueto, B. Celli, 2011, International journal of chronic obstructive pulmonary disease.

Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Impact of Frequency of Copd Exacerbations on Pulmonary Function, Health Status and Clinical Outcomes

A. Anzueto, A Anzueto, S. Kesten, 2022 .

A post hoc pooled analysis of exacerbations among US participants in randomized controlled trials of tiotropium.

M. Decramer, D. Niewoehner, A. Anzueto, 2013, Respiratory medicine.

Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year UPLIFT® Trial

M. Decramer, B. Celli, D. Halpin, 2011, Lung.

Evaluation of withdrawal of maintenance tiotropium in COPD.

D. D. Briggs, A. Anzueto, S. Adams, 2009, Respiratory medicine.

Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial

N. Metzdorf, M. Rutten-van Mölken, L. Goossens, 2014, BMC Pulmonary Medicine.

Chronic Obstructive Pulmonary Diseases : Journal of the COPD Foundation Effect of Tiotropium on Outcomes in Patients With COPD , Categorized Using the New GOLD Grading System : Results of the UPLIFT ® Randomized Controlled Trial

M. Decramer, B. Celli, D. Halpin, 2015 .

International Journal of Copd Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article in the Treatment of Copd: a Safety Review

M. Decramer, B. Celli, D. Tashkin, 2022 .

Statistical Analysis of the Micronucleus Test with the Fisher-Pitman Permutation Test

J. Ellenberger, I. Leimer, H. Peil, 1991 .

Tiotropium HandiHaler® in the treatment of COPD: A safety review

M. Decramer, B. Celli, D. Tashkin, 2009, International journal of chronic obstructive pulmonary disease.

International Journal of Copd Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article in the Treatment of Copd: a Safety Review

M. Decramer, B. Celli, D. Tashkin, 2022 .

Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes

A. Anzueto, I. Leimer, S. Kesten, 2009 .

Vascular Health and Risk Management Dovepress Screening for Type 2 Diabetes in a Multiethnic Setting Using Known Risk Factors to Identify Those at High Risk: a Cross-sectional Study

K. Khunti, T. Skinner, M. Davies, 2022 .

International Journal of Copd Dovepress Tiotropium Reduces Risk of Exacerbations Irrespective of Previous Use of Inhaled Anticholinergics in Placebo-controlled Clinical Trials

M. Decramer, A. Anzueto, B. Celli, 2022 .

Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes

I. Leimer, A. Anzueto, S. Kesten, 2009, International journal of chronic obstructive pulmonary disease.